Indication
stent
1 clinical trial
1 product
Clinical trial
Camrelizumab Combined With Neoadjuvant Chemotherapy After Stent Placement Versus Surgery Alone for Left-Sided Obstructive Colonic CancerStatus: Recruiting, Estimated PCD: 2023-12-30
Product
Camrelizumab